These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 8920248

  • 1. Models of the within-host dynamics of persistent mycobacterial infections.
    Antia R, Koella JC, Perrot V.
    Proc Biol Sci; 1996 Mar 22; 263(1368):257-63. PubMed ID: 8920248
    [Abstract] [Full Text] [Related]

  • 2. Understanding the phenomenon of persistence in mycobacterial infections.
    Gupta UD, Katoch VM.
    Indian J Lepr; 1997 Mar 22; 69(4):385-93. PubMed ID: 9474514
    [Abstract] [Full Text] [Related]

  • 3. Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis.
    David HL, Papa F, Cruaud P, Berlie HC, Maroja MF, Salem JI, Costa MF.
    Int J Lepr Other Mycobact Dis; 1992 Jun 22; 60(2):208-24. PubMed ID: 1522363
    [Abstract] [Full Text] [Related]

  • 4. Bacterial persistence in leprosy.
    Toman K.
    Int J Lepr Other Mycobact Dis; 1981 Jun 22; 49(2):205-17. PubMed ID: 6792087
    [Abstract] [Full Text] [Related]

  • 5. Chronic bacterial infections: living with unwanted guests.
    Young D, Hussell T, Dougan G.
    Nat Immunol; 2002 Nov 22; 3(11):1026-32. PubMed ID: 12407411
    [Abstract] [Full Text] [Related]

  • 6. Computerized mathematical model of M. leprae population dynamics during multiple drug therapy.
    Almeida JG, Chacko CJ.
    Indian J Lepr; 1985 Nov 22; 57(4):780-9. PubMed ID: 3915007
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases.
    Harboe M.
    Int J Lepr Other Mycobact Dis; 1992 Sep 22; 60(3):470-6. PubMed ID: 1474286
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R, Shahid F, Zafar S, Dojki M, Dockrell HM.
    Immunology; 2004 Apr 22; 111(4):462-71. PubMed ID: 15056384
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Change in cell-mediated immunity to Mycobacterium leprae and Mycobacterium marinum in Hansen's disease patients].
    Fliess EL, Ortiz MC, Corn J.
    Hansenol Int; 1983 Jun 22; 8(1):9-17. PubMed ID: 6432692
    [Abstract] [Full Text] [Related]

  • 18. [Slow growth rate of mycobacteria. Possible reasons and significance for their pathogenicity].
    Lewin A, Sharbati-Tehrani S.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Dec 22; 48(12):1390-9. PubMed ID: 16283122
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.